Galera Therapeutics, INC. (GRTX) SEC Filings — 2024
25 SEC filings for Galera Therapeutics, INC. (GRTX) in 2024.
Filings
- Galera Therapeutics Files 8-K on Key Corporate Events — 8-K · Dec 31, 2024
- Galera Therapeutics Files 8-K — 8-K · Dec 20, 2024
- Galera Therapeutics Files Q3 2024 10-Q — 10-Q · Dec 13, 2024
- Galera Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Oct 18, 2024
- Galera Therapeutics Faces Nasdaq Delisting — 8-K · Sep 4, 2024
- Galera Therapeutics Files Definitive Proxy Statement — DEF 14A · Sep 3, 2024
- Galera Therapeutics Appoints New Chief Medical Officer — 8-K · Aug 14, 2024
- Galera Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
- Galera Therapeutics Files 8-K for Regulation FD Disclosure — 8-K · Aug 8, 2024
- Galera Therapeutics Announces Leadership Changes and New Director Appointments — 8-K · Jun 7, 2024
- Galera Therapeutics Faces Nasdaq Delisting Warning — 8-K · Jun 3, 2024
- Galera Therapeutics, INC. SC 13G/A Filing — SC 13G/A · May 16, 2024
- Galera Therapeutics Files 8-K — 8-K · May 13, 2024
- Galera Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
- Galera Therapeutics Files 8-K: Material Agreements and Shareholder Rights — 8-K · May 3, 2024
- Galera Therapeutics, INC. SC 13G/A Filing — SC 13G/A · May 1, 2024
- Galera Therapeutics, INC. SC 13G Filing — SC 13G · Apr 16, 2024
- Galera Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Apr 3, 2024
- Galera Therapeutics Files 8-K on Financials — 8-K · Mar 28, 2024
- Galera Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
- Galera Therapeutics Faces Delisting Notice — 8-K · Mar 27, 2024
- Sofinnova Amends Galera Therapeutics Stake — SC 13D/A · Feb 20, 2024
- Galera Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Yair Schneid Takes 13.073% Stake in Galera Therapeutics — SC 13G · Jan 17, 2024
- GSA Capital Discloses 3.89M Share Stake in Galera Therapeutics — SC 13G · Jan 2, 2024